Document is current
Any future updates will be listed below
-
Authors
Shafrin, Jason
Marijam, Alen
Joshi, Ashish V.
Mitrani-Gold, Fanny S.
Everson, Katie
Tuly, Rifat
Rosenquist, Peter
Gillam, Michael
Ruiz, Maria Elena
-
Funding
Funding for this research was provided by:
GSK (212460, 212460, 212460, 212460, 212460, 212460, 212460, 212460, 212460)
- License Information
-
More Information
Article History
Received: 8 June 2022
Accepted: 17 October 2022
First Online: 4 November 2022
Declarations
:
: No direct subject contact or primary collection of individual human subject data occurred. Study results are in tabular form and presented as aggregate analyses that omit subject identification, therefore informed consent, ethics committee, or IRB approval was not required.
: No direct subject contact or primary collection of individual human subject data occurred. Study results are in tabular form and presented as aggregate analyses that omit subject identification; any publications and reports do not include subject identifiers, therefore consent was not required.
: JS is a former employee of Precision Medicine Group, which received funding from GSK to conduct this study. AM is an employee of and shareholder in GSK. AVJ is an employee of and shareholder in GSK. FSM-G is an employee of and shareholder in GSK. KE is an employee of Precision Medicine Group, which received funding from GSK to conduct this study. RT is a former employee of Precision Medicine Group, which received funding from GSK to conduct this study. PR is a former employee of Precision Medicine Group, which received funding from GSK to conduct this study. MG is an employee of MedStar Health and received funding from GSK through Precision Medicine Group to conduct this study. MER is a former employee of MedStar Health and received funding from GSK through Precision Medicine Group to conduct this study. Trademarks are owned by or licensed to their respective owners (Elsevier [ProspectoRx]; Cerner Corporation [Cerner electronic health platform]).
